To quantify changes in menopause-related online searches compared with other health domains over a 20-year period.
Key Findings:
The commercialization index increased by approximately 15 to 20 percentage points in the US, UK, and Australia from 2010 to 2025.
By 2025, about 1 in 3 menopause-related searches were commercial, compared to roughly 1 in 5 to 7 in 2010.
The highest volume commercial searches were related to supplements and digital services.
Interpretation:
The increase in the commercialization index indicates a shift in the relative composition of menopause-related searches towards commercial content, with informational searches growing faster.
Limitations:
Google Trends reflects relative rather than absolute search interest.
Search behavior does not directly capture clinical behavior or information quality.
Conclusion:
The study provides empirical evidence of increasing commercialization in menopause-related search behavior, highlighting the need for clinical guidance to compete with product-led messaging.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
A large Epic Cosmos analysis linked vaginal estrogen prescribing with lower rates of sepsis, hospital admission, and death following recurrent urinary tract infection, but researchers cautioned that prescribing may also mark broader differences in care.
